Abstract Subcutaneous ICD (S-ICD™) therapy has been established in initial clinical trials
and current international guideline recommendations for patients without demand for …

Sudden Cardiac Death (SCD) is a significant health problem worldwide. Multiple
randomized controlled trials have shown that Implantable Cardioverter Defibrillators (ICDs) …

Background and objective Worldwide adoption of the subcutaneous implantable
cardioverter‐defibrillator (S‐ICD) for preventing sudden cardiac death continues to increase …

Operative anesthetic requirements and perioperative discomfort are barriers to wide
adoption of the subcutaneous implantable cardioverter–defibrillator (SICD) system. The …

Background During early experience with subcutaneous implantable cardioverter-
defibrillators (S-ICD), several patients had inappropriate shocks from T-wave oversensing …

Purpose Operative anaesthetic requirements and perioperative discomfort are barriers to
wide adoption of the subcutaneous implantable cardioverter defibrillator (S-ICD) system …

Background The perioperative anticoagulation management during subcutaneous
implantable cardioverter-defibrillator (S-ICD) implantation is still evolving. Objective The …

Many clinical challenges have been encountered in electrophysiology laboratories (EP)
while implanting intracardiac defibrillators for lethal arrhythmias, using pacemakers for …

Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) system is an
established therapy for the prevention of sudden cardiac death (SCD) and an alternative to a …

Purpose To assess the feasibility and safety of same-day discharge after S-ICD implantation
by implementing a specific analgesia protocol and phone follow-up. Methods Consecutive …